Article Information
History
- September 11, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1The Third Affiliated Hospital of Xinxiang Medical University, Department of clinical laboratory, Xinxiang 453000, China
- 2Guangdong nephrotic drug Engineering Technology Research Center, Institute of Consun Co. for Chinese Medicine in Kidney Diseases, Guangdong Consun Pharmaceutical Group, Guangzhou 510530, China
- * Corresponding author; email: yangjunzheng606403{at}163.com